Berlin - Delayed Quote EUR

CytomX Therapeutics Inc (6C1.BE)

1.9110
-0.1870
(-8.91%)
As of 4:16:04 PM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
138,103
138,103
101,214
53,163
37,312
Operating Expense
113,108
113,108
107,698
154,498
153,354
Operating Income
24,995
24,995
-6,484
-101,335
-116,042
Net Non Operating Interest Income Expense
7,136
7,136
9,837
1,678
255
Other Income Expense
-38
-38
-30
340
-83
Pretax Income
32,093
32,093
3,323
-99,317
-115,870
Tax Provision
224
224
3,892
0
0
Net Income Common Stockholders
31,869
31,869
-569
-99,317
-115,870
Diluted NI Available to Com Stockholders
31,869
31,869
-569
-99,317
-115,870
Basic EPS
0.38
0.38
-0.01
-1.51
-1.30
Diluted EPS
0.38
0.38
-0.01
-1.51
-1.30
Basic Average Shares
84,439.3030
84,439.3030
73,808.2370
65,739.8440
64,146.8480
Diluted Average Shares
84,745.1160
84,745.1160
73,808.2370
65,739.8440
64,146.8480
Total Operating Income as Reported
24,995
24,995
-6,484
-101,335
-116,042
Total Expenses
113,108
113,108
107,698
154,498
153,354
Net Income from Continuing & Discontinued Operation
31,869
31,869
-569
-99,317
-115,870
Normalized Income
31,869
31,869
-569
-99,317
-115,870
Interest Income
7,136
7,136
9,837
1,678
255
Net Interest Income
7,136
7,136
9,837
1,678
255
EBIT
24,995
24,995
-6,484
-101,335
-116,042
EBITDA
26,763
26,763
-4,309
-98,892
-113,336
Reconciled Depreciation
1,768
1,768
2,175
2,443
2,706
Net Income from Continuing Operation Net Minority Interest
31,869
31,869
-569
-99,317
-115,870
Normalized EBITDA
26,763
26,763
-4,309
-98,892
-113,336
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/25/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

226950.KQ OliX Pharmaceuticals, Inc
46,350.00
+4.86%
 
N04.MU Nucana PLC R
0.0460
+35.29%
 
N04.SG Nucana PLC (ADRs)
0.0310
+19.23%
 
N04.F NuCana plc
0.0300
+200.00%
 
N04.BE Nucana PLC R
0.0845
+10.46%
 
HEMO.L Hemogenyx Pharmaceuticals Plc
178.49
-0.15%
 
POLB.L Poolbeg Pharma PLC
2.8700
-1.03%
 
XCUR Exicure, Inc.
10.49
-1.69%
 
TCBPY TC Biopharm (Holdings) Plc
0.3000
-7.32%
 
GLYC GlycoMimetics, Inc.
0.2417
+1.10%